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Aim To determine the pattern of breast diseases among 
Saudi patients who underwent breast biopsy, with special 
emphasis on breast carcinoma.
Methods A retrospective review was made of all breast bi-
opsy reports of a mass or lump from male and female pa-
tients seen between January 2001 and December 2010 at 
the King Khalid University Hospital, Riyadh, Saudi Arabia.
Results Of 1035 breast tissues reviewed, 939 specimens 
(90.7%) were from female patients. There were 690 benign 
(65.8%) and 345 (34.2%) malignant cases. In women, 603 
(64.2%) specimens were benign and 336 (35.8%) were ma-
lignant. In men, 87 specimens (90.6%) were benign and 9 
(9.4%) were malignant. All malignant cases from male pa-
tients belonged to invasive ductal carcinoma and the ma-
jority of malignant cases from female patients belonged 
to invasive/infiltrating ductal carcinoma. The proportion 
of malignancy was 18% in patients younger than 40 years 
and 63.2% in patients older than 60 years. The mean age 
of onset for malignancy was 48.6 years. The annual per-
centage incidence of malignant breast cancer steadily in-
creased by 4.8%, from an annual rate of 23.5% in 2000 to 
47.2% in 2007.
Conclusion Among Saudi patients, there is a significant 
increase in the incidence of breast cancer, which occurs at 
an earlier age than in western countries. Continued vigi-
lance, mammographic screening, and patient education 
are needed to establish early diagnosis and perform op-
timal treatment.
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Increased awareness and efficient breast cancer informa-
tion-dissemination  campaign  led  to  an  increased  num-
ber  of  diagnosed  cases  of  breast  cancer.  According  to 
the  American  Cancer  Society,  about  1.3  million  Ameri-
can women annually are diagnosed with breast cancer 
and about 465 000 die from the disease (1). The number 
of deaths has decreased since 1990, probably due to an 
earlier detection and advances in treatment. According to 
2000-2004 Saudi National Cancer Registry data, there were 
127.8 per 100 000 women with breast cancer and mortality 
rate was 25.5 per 100 000 (2).
Most palpable breast masses are benign; less than 30% of 
women with palpable masses have a diagnosis of cancer 
(3-5).  Approximately  4%  of  breast  cancers  present  with 
a  palpable  mass  without  mammographic  or  ultrasono-
graphic evidence of the disease (6). Therefore, evaluation 
of a breast mass should be done by taking into consider-
ation patient’s history, physical examination, imaging, and 
biopsy. Definitive diagnosis in nearly all cases is established 
by needle biopsy. Because of the low specificity of mam-
mography,  many  women  undergo  unnecessary  breast 
biopsy. As many as 65%-85% of breast biopsies are per-
formed on benign lesions (7), which subjects the patients 
to avoidable emotional and physical burden.
Similarly to other countries, breast cancer in Saudi Arabia is 
the most common cancer in women (7). The Saudi Nation-
al Cancer Registry reported a rising proportion of breast 
cancer among women of all ages, from 10.2% in 2000 to 
24.3% in 2005 (8). A significant majority of these breast 
cancers (almost 80%) were of the infiltrating ductal type. 
The average age at presentation of breast cancer in Arab 
countries is 48 years, which is a decade earlier than in west-
ern countries (9). The median age of onset of breast cancer 
among Saudi women is 46 years (8). Due to the increasing 
incidence, several articles have been published on screen-
ing for breast cancer and on public awareness programs 
initiated by the Saudi Arabian government and non-gov-
ernmental sectors (10-13). This study aims to describe the 
epidemiological characteristics of breast mass lesions of 
patients examined at the King Khalid University Hospital, 
Riyadh, Saudi Arabia from 2001 to 2010.
MAteRiAlS And MetHodS
This  retrospective  study  included  histopathological  re-
ports of all patients (including male patients) who had 
undergone biopsy of breast masses or lesions between 
January 2001 and December 2010 at the King Khalid 
University Hospital, which is a large (1000 beds) tertiary re-
ferral hospital with a large patients catchment area cover-
ing the northern part of Riyadh. Data were extracted from 
the hospital computer database and entered into an Excel 
sheet. Demographic data included age at diagnosis and 
sex. Histomorphological features were classified as benign 
or malignant based on the 2003 World Health Organiza-
tion classification of tumors of the breast (14). Data were 
analyzed using Predictive Analytical Software, version 18 
(IBM, SPSS Inc., Chicago, IL, USA) and expressed as mean, 
standard deviation, and percentages. Validation was per-
formed by random re-examination by the two authors of 
15% of the histopathology slides representing the various 
breast lesions.
ReSultS
A total of 1035 breast tissue specimens were examined 
between January 2001 and December 2010 at the Pathol-
ogy Department of the King Khalid University Hospital. 
There were 939 specimens (90.7%) from female and 96 
(9.3%) from male patients. Histopathology revealed 681 
(65.8%) benign and 354 (34.2%) malignant cases. The av-
erage age at diagnosis of all patients with malignancy was 
48.6 ± 11.6 years.
Among men, benign breast lesions mostly occurred in 
patients younger than 40 years, while malignant lesions 
occurred in patients aged 40 and older (Table 1). Among 
women, benign breast lesions also mostly occurred in pa-
tients younger than 40 years and the majority of those 
cases (more than 50%) were fibroadenomas. The medi-
an age of onset of breast cancer in our population was 
48.0 years (range, 20-91 years). However, the proportion of 
malignancy progressively increased from 18% in the age 
group 20-39 years to 53.3% in the age group 40-59 years, 
tAble 1. breast lesions detected in male patients with age 
distribution
Age groups in years, n (%)
<20 20-39 40-59
60 and 
above total
benign (n = 87):
gynecomastia 18 (90.0) 53 (88.3) 5 (50) - 76 (79.2)
fibroadenoma   1 (5.0) 3 (5) 1 (10) -   5 (5.2)
lipoma   1 (5.0) 4 (6.7) - -   5 (5.2)
trichoadenoma 1 (16.7)   1 (1.0)
Malignant (n = 9):
invasive ductal 
carcinoma
- - 4 (40) 5 (83.3)   9 (9.4)
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and as much as 63.2% of patients were more than 60 years 
old (Table 2).
The yearly percentage incidence of malignant breast neo-
plasms  (in  terms  of  percentage  distribution)  showed  a 
steady rise over the years, as compared to benign breast 
lesions. In 2000, 76.5% of the tissues submitted for histo-
pathology were benign and only 23.5% were malignant. 
From 2000 to 2007, there was a steady rise by a mean of 
4.8% in the annual incidence of malignant breast lesions, 
with the exception of 2003, when there was a slight de-
crease. The annual rate of a malignant breast lesions con-
firmed  by  histopathological  examination  ranged  from 
23.5% in 2000 to 47.2% in 2007. In contrast, after 2007, 
there was a shift of the trend toward more benign cases 
(Figure 1). There was, however, an overall increase in the 
percentage of people diagnosed with breast cancer from 
23.5% in 2000 to 34.5% in 2010.
diScuSSion
In this study, the majority of breast lesions sent for histo-
pathology were fibroadenomas, constituting 423 of 1035 
(40.9%) breast specimens received in our laboratory. This 
finding is similar to other reports (1,2). Such patients were 
predominantly young, with age range from 18 to 78 years 
in women. Although fibroadenomas are not cancerous or 
life-threatening lesions they can still be a source of signifi-
cant anxiety and concern to the patient.
Our study found a malignancy rate of 33.3% (ie, 345 out 
of 1035 cases were malignant). It is a high rate, compared 
to the rate reported in the literature that was lower than 
30% (3-5). Furthermore, our incidence rate was significant-
ly higher than the incidence rate of 24.3% reported by the 
Saudi National Cancer Registry in 2005 (8). This difference 
may be explained by an increase in the use of mammog-
raphy, effectiveness of breast cancer awareness program 
tAble 2. breast lesions seen in female breasts with age distribution
Age groups in years, n (%)
<20 20-39 40-59 60 and above total
benign (n = 603):
fibroadenoma 57 (85.1) 218 (56.3) 132 (31.7) 11 (16.2) 418 (69.3)
normal   5 (7.5)   32 (8.3)   26 (6.2)   2 (2.9)   65 (10.8)
duct ectasia  -   14 (3.6)     7 (1.7)   5 (7.4)   26 (4.3)
granulomatous mastitis   1 (1.5)   13 (3.4)   10 (2.4)   1 (1.5)   25 (4.1)
abscess  -   12 (3.1)     4 (0.9)   16 (2.7)
lipoma   3 (4.5)     7 (1.8)     4 (0.9)   2 (2.9)   16 (2.7)
intraductal papilloma   1 (1.5)     3 (0.8)     7 (1.7)   3 (4.4)   14 (2.3)
fat necrosis  -     8 (2.1)     2 (0.5)   1 (1.5)   11 (1.8)
epidermal inclusion cyst  -     3(0.8)     1 (0.2)  -     4 (0.7)
galactocoele  -     4 (1.0)  -  -     4 (0.7)
benign phyllodes tumor  -     3(0.8)     1 (0.2)  -     4 (0.7)
Malignant (n = 336):  
invasive ductal carcinoma  -   66 (17.0) 217 (52.0) 40 (58.8) 323 (96.1)
malignant phyllodes tumor  -     2 (0.5)     3 (0.7)   1 (1.5)     6 (1.8)
medullary breast cancer  -     2 (0.5)     1 (0.2)  -     3 (0.9)
mucinous colloid carcinoma  -  -     1 (0.2)   2 (2.9)     3 (0.9)
inflammatory carcinoma  -  -     1 (0.2)  -     1 (0.3)
total 67 (7.1) 387 (41.2) 417 (44.4) 68 (7.2) 939
FiguRe 1. Annual percentage and distribution of benign vs 
malignant cases of breast lesions over a period of ten years. 
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that has been initiated by the government, the effective 
campaign organized by various health authorities in order 
to educate the public on early detection of breast cancer 
through self breast examination, or sample bias (10-13). In 
our study, infiltrating/invasive ductal carcinoma was the 
most common malignant type of breast cancer (96.2%), 
with a slightly higher rate than that reported by the Saudi 
National Cancer Registry (8). Patients diagnosed with breast 
cancer were in the age groups ranging from 28 to 78 years; 
however most of the women were in the age group 40-59 
years (97.3%) (8). The age of onset of breast cancer in our 
patients was similar to that previously reported (9) but was 
slightly higher than that reported by the Saudi National 
Cancer Registry (8).
Although  our  findings  did  not  substantially  differ  from 
those in previous studies in terms of the age of presen-
tation of breast cancer, histopathological types, or even 
the ratio of benign to malignant cases, we believe that it 
is necessary to point out the steady rise in the incidence of 
breast cancer since 2000, with a mean annual increase of 
4.8%. This rate is higher than the reported annual increase 
in the proportion of breast cancer of 2% in the UK (15) and 
higher than the annual average increase of 0.4% in the 
USA (16). This trend can be explained either by an effec-
tive awareness program and efficient patient education on 
breast self-examination or by sample bias as our patients 
came from only one referral center. It is also important to 
emphasize that breast cancer remains the leading cause of 
death among the Saudi women.
Furthermore, we noticed a changing pattern in the pro-
portion of breast cancer cases in the last 3 years (2007 to 
2010). Before 2007, most of the breast specimens were be-
nign cases, with an increasing annual incidence of malig-
nant cases. However, after 2007, the trend shifted toward 
benign cases. In our opinion, this is a reflection of an ef-
fective campaign of breast diseases awareness programs. 
Nevertheless, this trend should not be a reason for com-
placency, since some of these benign cases, though not 
cancerous, may indicate an increased risk toward the de-
velopment of pre-malignant conditions such as fibroad-
enomas  (17).  Another  point  of  paramount  importance, 
highlighted in this and other studies (9,15), is that among 
Saudi  patients  breast  carcinoma  occurs  in  relatively 
younger age groups than is the case in Western patients. 
This could be due to the demography of the Saudi pop-
ulation, which is characterized by a predominance of a 
younger population (more than 60% of the population 
is under 18 years) (8).
An important limitation of this study is its retrospective na-
ture and, although our study covered a large catchment 
area, all the data were from one tertiary referral hospital, 
which is why they might not be representative of the entire 
country. There is a need for a larger study involving various 
medical centers that would also examine other environ-
mental, genetic, and dietary factors that may contribute to 
the incidence of breast diseases in this part of the world.
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